Health stocks hit after Trump taps RFK for top job
The news prompted a sell-off across the industry. In the US, shares in Pfizer and Moderna sank more than 5% in early trading, while UK-listed firms AstraZeneca and GSK dropped 2% or more. Russ Mould, investment director at AJ Bell, said the pick had “spooked” shareholders, despite questions about how the new administration might pursue its threats.
Snow White, Donald Trump and Rachel Zegler
Trump, Judges
Plus: Is Trump signaling a retribution agenda with Gaetz, and other picks for his administration? These and mores stories on ...
GOP lawmakers have likened the new drug negotiation law to "government price controls" reducing drug companies' research into ...
The Department of Government Efficiency, led by Elon Musk and Vivek Ramaswamy, aims to cut "wasteful" spending by defunding ...
Americans ages 18 to 29 swung toward President-elect Donald Trump in this year’s election, but they came to his coalition ...
In 2016, Carlson sued Fox News’ former chief executive, Roger Ailes, claiming she was cut loose after she refused his sexual ...
It’s far from certain the Murdoch empire can win over the MAGA movement as Musk and Rogan erode the influence of legacy media ...
President-elect Donald Trump has a vision for education that revolves around a single goal: to rid America’s schools of ...
Smith's federal criminal cases against Trump were upended by the election, as the Justice Department's longstanding policy is ...
Big Tech stocks have had a relatively muted reaction to Donald Trump’s election victory, as investors parse how his second ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback